David R. Spring

University of Cambridge

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Development and proof-of-concept for a photoswitchable peptide staple with the ability to trigger a major change in binding affinity upon visible light irradiation.

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Zoe R Maylin

The University of British Columbia

CANADA

View details

Sophie Jackson

Professor in Chemical and Molecular Biology

University of Cambridge

UNITED KINGDOM

View details

Paul H. Edelstein

UNITED KINGDOM

View details

F. Javier Pérez-Areales

Assistant Professor

University of Barcelona

SPAIN

View details

Marko Hyvönen

University of Cambridge

UNITED KINGDOM

View details

Mauro Salvi

Associate Professor

ITALY

View details

Soleilmane Omarjee

Université Claude Bernard Lyon 1 - Domaine de Rockefeller

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

David R. Spring

Research Interests

Explore related searches

Contact this professor

Articles (17)

Red-light modulated <i>ortho</i>-chloro azobenzene photoswitch for peptide stapling <i>via</i> aromatic substitution

Red-light modulated ortho-chloro azobenzene photoswitch for peptide stapling via aromatic substitution

Site-selective peptide functionalisation mediated via vinyl-triazine linchpins

The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance

Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023)

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance

Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI-001 in in vitro Models of Prostate Cancer Drug Resistance

Peroxide-cleavable linkers for antibody–drug conjugates

A recombinant approach for stapled peptide discovery yields inhibitors of the RAD51 recombinase

Tryptophan in Multicomponent Petasis Reactions for Peptide Stapling and Late‐Stage Functionalisation

Tryptophan in Multicomponent Petasis Reactions for Peptide Stapling and Late‐Stage Functionalisation

A cell-active cyclic peptide targeting the Nrf2/Keap1 protein–protein interaction

Divinylpyrimidine reagents generate antibody–drug conjugates with excellent in vivo efficacy and tolerability

Development of small cyclic peptides targeting the CK2α/β interface

All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading

A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action

Antibody dual-functionalisation enabled through a modular divinylpyrimidine disulfide rebridging strategy

Collaborators (7)

Zoe R Maylin

Sophie Jackson

Paul H. Edelstein

F. Javier Pérez-Areales

Marko Hyvönen

Mauro Salvi

Soleilmane Omarjee

Make your next move.